| Date | Form | Description | Docs | XBRL | Pages |
| 08/24/10 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/20/10 | 8-K | Current report filing |
|
3 | |
| 07/27/10 | CT ORDER | Confidential treatment order |
|
1 | |
| 07/27/10 | UPLOAD | SEC-generated letter |
|
1 | |
| 07/21/10 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
11 | |
| 07/20/10 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
32 | |
| 07/20/10 | 8-K | Current report filing |
|
41 | |
| 06/29/10 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
5 | |
| 06/29/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
81 | |
| 06/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Read More...Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...